Foghorn Therapeutics Inc.FHTXNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
12.31%
↑ 521% above average
Average (28q)
-2.92%
Historical baseline
Range
High:46.71%
Low:-49.04%
Volatility
-3273.7%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 12.31% |
| Q2 2025 | 7.93% |
| Q1 2025 | 4.55% |
| Q4 2024 | -0.64% |
| Q3 2024 | 10.44% |
| Q2 2024 | 5.54% |
| Q1 2024 | -10.75% |
| Q4 2023 | -49.04% |
| Q3 2023 | 46.71% |
| Q2 2023 | 3.80% |
| Q1 2023 | -4.49% |
| Q4 2022 | -12.83% |
| Q3 2022 | 3.18% |
| Q2 2022 | -4.98% |
| Q1 2022 | 0.99% |
| Q4 2021 | -6.93% |
| Q3 2021 | -12.90% |
| Q2 2021 | -0.57% |
| Q1 2021 | -11.31% |
| Q4 2020 | -12.39% |
| Q3 2020 | -18.98% |
| Q2 2020 | -13.23% |
| Q1 2020 | 9.63% |
| Q4 2019 | -15.92% |
| Q3 2019 | -14.92% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |